C9orf72 and frontotemporal dementia: Elevated p62 levels have previously been reported in CNs derived from iPSCs of FTD patients carrying hexanucleotide expansions in C9orf72, and it is a pathological marker in post‐mortem analysis from C9orf72 carriers 5, 7.